Mandarin In.sg Regulatory News (MDO)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO CANADA, JAPAN, MALAYSIA, THE REPUBLIC OF SOUTH AFRICA, SWITZERLAND, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.

To: Business Editor For immediate release

1 FOR 4 RIGHTS ISSUE TO RAISE US$316 MILLION

5th March 2015 - Mandarin Oriental International Limited today announced a fully underwritten Rights Issue to raise gross proceeds of US$316 million. Mandarin Oriental's full year preliminary results for the year ended 31st December 2014 have also been released today in an accompanying announcement.

Summary

· The 1 for 4 fully underwritten Rights Issue of up to 250,930,919 New Ordinary Shares will raise gross proceeds of US$316 million.

· The issue price of US$1.26 per New Ordinary Share represents a discount of 28.4% to the closing price on 4th March 2015, and a 24.1% discount to the theoretical ex-rights price.

· The proceeds of the Rights Issue will enable Mandarin Oriental to retire debt and reduce gearing towards the levels that prevailed before the acquisition of the freehold of the Paris hotel. This will also provide the Group with the capacity to finance the £85 million (approximately US$130 million) renovation of Mandarin Oriental Hyde Park, London, due to start in 2016, and leave it well placed to make further investments.

· Jardine Strategic Holdings Limited, which has irrevocably undertaken to take up its entitlement under the Rights Issue, is also fully underwriting the balance of the Rights Issue.

Commenting on the Rights Issue, Mandarin Oriental Chairman, Mr Ben Keswick, said:

"The development strategy of Mandarin Oriental includes the holding of equity interests in selected landmark properties, and a strong balance sheet is important for the execution of this strategy. It enables the Group to maintain the quality of its properties and take advantage of further investment opportunities."

It is expected that the Prospectus will be published on 12th March 2015 containing full details of the Rights Issue. Once published, the Prospectus will be made available on the Company's website (www.mandarinoriental.com/investors/regulatory-announcements/), and will be submitted to the National Storage Mechanism and be available for inspection at www.morningstar.co.uk/uk/nsm.

For further information, please contact:

Mandarin Oriental Hotel Group International Limited

Stuart Dickie (852) 2895 9288

J.P. Morgan Cazenove

Joint Corporate Broker

Ed Squire / Bronson Albery (44) 20 7742 4000

UBS

Joint Corporate Broker

Stuart Mackay (852) 2971 8888

David James (44) 20 7567 8421

THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND DOES NOT CONSTITUTE A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT. NOTHING IN THIS ANNOUNCEMENT SHOULD BE INTERPRETED AS A TERM OR CONDITION OF THE RIGHTS ISSUE. ANY DECISION TO PURCHASE, OTHERWISE ACQUIRE, SUBSCRIBE FOR, SELL OR OTHERWISE DISPOSE OF ANY NEW ORDINARY SHARES MUST BE MADE ONLY ON THE BASIS OF THE INFORMATION CONTAINED IN AND INCORPORATED BY REFERENCE INTO THE PROSPECTUS. COPIES OF THE PROSPECTUS WILL BE AVAILABLE ON PUBLICATION FROM THE OFFICE of the Group Management Company, Mandarin Oriental Hotel Group International Limited, AT 7TH FLOOR, 281 GLOUCESTER ROAD, CAUSEWAY BAY, HONG KONG, AND ON THE COMPANY'S WEBSITE: WWW.MANDARINORIENTAL.COM/INVESTORS/REGULATORY-ANNOUNCEMENTS/.

J.P. Morgan Cazenove is authorized by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom. J.P. Morgan Cazenove is acting as corporate broker for the Company and is acting for no one else in connection with the Rights Issue and will not regard any other person as a client in relation to the Rights Issue and will not be responsible to anyone other than the Company for providing the protections afforded to its clients, or for providing advice in connection with the Rights Issue or any other matter, transaction or arrangement referred to in this announcement.

UBS is authorized and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom. UBS is acting as corporate broker for the Company and is acting for no one else in connection with the Rights Issue and will not regard any other person as a client in relation to the Rights Issue and will not be responsible to anyone other than the Company for providing the protections afforded to its clients, or for providing advice in connection with the Rights Issue or any other matter, transaction or arrangement referred to in this announcement.

The Rights Issue is being underwritten by Jardine Strategic Holdings Limited ('Jardine Strategic').

This announcement has been issued by, and is the sole responsibility of, the Company. Apart from the responsibilities and liabilities, if any, which may be imposed on Jardine Strategic, J.P. Morgan Cazenove and UBS under the Financial Services and Markets Act 2000 or the regulatory regime established thereunder or any other applicable regulatory regime, none of Jardine Strategic, J.P. Morgan Cazenove or UBS accepts any responsibility or liability whatsoever and makes no representation or warranty, express or implied, in relation to the contents of this announcement, including its accuracy, completeness or verification or for any other statement made or purported to be made by them, or on their behalf, in connection with the Company, the Nil Paid Rights, the Nil Paid Rights Allocations, the New Ordinary Shares or the Rights Issue. Jardine Strategic, J.P. Morgan Cazenove and UBS accordingly disclaim, to the maximum extent permitted by law, all and any responsibility and liability, whether arising in tort, contract or otherwise, which they might otherwise be found to have in respect of this announcement or any such statement.

The information contained herein is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part in, into or from Canada, Japan, Malaysia, the Republic of South Africa, Switzerland, the United States (the 'Restricted Territories') or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. The securities to be issued in connection with the Rights Issue (the 'Securities') have not been and will not be registered under the securities laws of such jurisdictions and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within such jurisdictions except pursuant to an exemption from and in compliance with any applicable securities laws.

This announcement is for information purposes only and does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in any jurisdiction and should not be relied upon in connection with any decision to subscribe for or acquire any of the Securities. In particular, this announcement does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in the Restricted Territories or any other jurisdiction in which such an offer or solicitation would be unlawful.

Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. You should not place undue reliance on forward-looking statements, which speak only as of the date of this announcement.

This announcement and the information contained herein does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States. The Securities have not been and will not be registered under the US Securities Act of 1933 (the 'Securities Act'), and may not be offered or sold in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Securities will not be registered under or offered in compliance with applicable securities laws of any state, province, territory, county or jurisdiction of the United States or the other Restricted Territories. Accordingly, unless an exemption under the relevant securities law is applicable, the Securities may not be offered, sold, taken up, exercised, renounced, resold, delivered or distributed, directly or indirectly, in or into the United States or the other Restricted Territories or any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration thereof in, such jurisdiction. There will be no public offering of the Securities in the United States.

5th March 2015

MANDARIN ORIENTAL INTERNATIONAL LIMITED

1 FOR 4 RIGHTS ISSUE OF UP TO 250,930,919 NEW ORDINARY SHARES AT US$1.26 EACH

Principal Terms of the Rights Issue

Mandarin Oriental is proposing to offer up to 250,930,919 New Ordinary Shares by way of a Rights Issue to Qualifying Shareholders. Such number of New Ordinary Shares represents approximately 25.0% of the existing issued share capital and 20.0% of the Enlarged Share Capital.

The Rights Issue is expected to raise approximately US$313 million, net of expenses, and will be made on the basis of:

1 New Ordinary Share at US$1.26 each for every 4 Existing Ordinary Shares

held by Qualifying Shareholders at the close of business on the Record Date.

The Issue Price represents a 24.1% discount to the theoretical ex-rights price based on the closing price of US$1.76 per Ordinary Share on Wednesday, 4th March 2015 (being the last business day before the announcement of the terms of the Rights Issue).

Entitlements to New Ordinary Shares will be rounded down to the nearest whole number. Fractional entitlements will be disregarded and will not be allotted.

The Group's Strategy

The Group aims to be recognized as a leading global brand, based on the management or ownership of many of the world's most sought-after luxury hotels and by investing in the Group's facilities and its people. The Group plans to open its hotels currently under development while continuing to seek further opportunities for expansion, with the objective of achieving long-term growth in earnings and net assets per share and increasing the number of rooms under operation to 10,000. A strong balance sheet is intrinsic to the execution of this strategy, enabling the Group to maintain the quality of its properties at all times and to acquire equity holdings in hotels when appropriate.

Reasons for the Rights Issue

In line with the Group's strategy, the additional capital being raised through the Rights Issue will enable Mandarin Oriental to retire debt and reduce gearing towards the levels that prevailed before the acquisition of the freehold of the Paris hotel. This will also provide the Group with the capacity to finance the £85 million (approximately US$130 million) renovation of Mandarin Oriental Hyde Park, London and leave it well placed to make further investments. The London renovation, which is due to start in 2016, will significantly re-position this flagship property and enhance the Mandarin Oriental brand in a key market.

Further terms of the Rights Issue

Conditions

The Rights Issue is subject to certain conditions, including:

(i) the Underwriting Agreement for the Rights Issue having become unconditional in all respects save for the condition relating to UK Admission;

(ii) UK Admission becoming effective by no later than Tuesday, 17th March 2015 (or such later date as Jardine Strategic and the Company may agree); and

(iii) dealings in the Nil Paid Rights Allocations commencing on the Singapore Exchange no later than Tuesday, 17th March 2015 (or such later date as Jardine Strategic and the Company may agree).

A shareholder resolution authorizing the allotment of further shares in the Company was passed at the annual general meeting of the Company held on 7th May 2014.

Payment

The offer price is payable in full on acceptance in US dollars only:

· by holders of the Nil Paid Rights Allocations who are Entitled Depositors, by no later than:

(i) 5.00 p.m. (Singapore time) on Thursday, 2nd April 2015 if acceptance and payment is made through CDP by way of US dollar cashier's order or demand draft drawn on a bank in Singapore; or

(ii) 9.30 p.m. (Singapore time) on Thursday, 2nd April 2015 if acceptance and payment is made by way of Electronic Application through an ATM of a Participating Bank; and

· by holders of the Nil Paid Rights who are not Depositors, by way of banker's draft by no later than 11.00 a.m. (Singapore or London time, as the case may be) on Tuesday, 7th April 2015.

Listings

Application has been made to the UK Listing Authority and to the London Stock Exchange for the New Ordinary Shares (nil paid and fully paid) to be admitted to the standard listing segment of the Official List of the UK Listing Authority and to trading on the Main Market for listed securities of the London Stock Exchange, respectively. It is expected that UK Admission will become effective and that dealings on the London Stock Exchange in the New Ordinary Shares (nil paid) will commence at 8.00 a.m. (London time) on Tuesday, 17th March 2015, and that dealings in the New Ordinary Shares (fully paid) will commence at 8.00 a.m. (London time) on Wednesday, 8th April 2015.

Application has also been made to the Bermuda Stock Exchange for quotation of the New Ordinary Shares. It is expected that the Bermuda Admission will become effective and that dealings on the Bermuda Stock Exchange in the New Ordinary Shares (fully paid) will commence at 8.00 a.m. (Bermuda time) on Wednesday, 8th April 2015.

Application will also be made to the Singapore Exchange for the listing of, and quotation for, the New Ordinary Shares (fully paid). It is expected that dealings on the Singapore Exchange in the Nil Paid Rights Allocations will commence at 9.00 a.m. (Singapore time) on Tuesday, 17th March 2015, and that Singapore Admission and dealings in the New Ordinary Shares (fully paid) will commence at 9.00 a.m. (Singapore time) on Wednesday, 8th April 2015.

Further terms

The New Ordinary Shares, when issued and fully paid, will rank pari passu in all respects with the Existing Ordinary Shares, including the right to receive dividends or distributions made, paid or declared after the date of issue of the New Ordinary Shares, other than the final dividend in respect of 2014 of US¢5.00 per Existing Ordinary Share.

Details of further terms and conditions of the Rights Issue, including the procedure for acceptance and payment and the procedure in respect of rights not taken up, will be set out in the Prospectus and, where relevant, will also be set out in the PAL or the RAF (as appropriate).

Underwriting and Jardine Strategic

Jardine Strategic, which currently owns 73.45% of the issued Existing Ordinary Shares, has irrevocably undertaken to take up its entitlement of 184,318,820 New Ordinary Shares. In addition, Jardine Strategic has agreed to underwrite the balance of the Rights Issue pursuant to the Underwriting Agreement, representing 66,612,099 Underwritten Shares, for an underwriting commission of 1.5% of the aggregate value of the Underwritten Shares at the Issue Price. The principal terms of the Underwriting Agreement will be summarized in the Prospectus.

Following the Rights Issue, assuming no Share Options are exercised and no Share Awards become vested between 4th March 2015 (being the latest practicable date prior to the publication of this announcement) and completion of the Rights Issue:

(i) to the extent all Qualifying Shareholders and Entitled Depositors take up their respective rights under the Rights Issue in full, the proportionate shareholdings in the Company's issued share capital will remain unchanged; and

(ii) if no Qualifying Shareholder or Entitled Depositor (other than Jardine Strategic) takes up rights under the Rights Issue and if no placees for the New Ordinary Shares which are not taken up are procured in accordance with the Placing Agreement, the proportionate shareholding of Jardine Strategic (and, through Jardine Strategic, Jardine Matheson) in the Company's issued share capital would increase from 73.45% to 78.76%, and the proportionate shareholding of existing Shareholders would be diluted by 20.0%, as a result of the underwriting by Jardine Strategic.

Current Trading, Trends and Prospects

On 5th March 2015, the Company announced its results for the year ended 31st December 2014.

Overview

Against the background of challenging conditions in some markets, Mandarin Oriental did well to achieve an improvement in underlying profit in 2014. The Group benefited from resilient demand from the leisure sector, the geographic diversification of its portfolio and the receipt of branding fees related to its Residences projects.

Group Review

In Hong Kong, the Group's two wholly-owned hotels performed well compared to last year, although their results were impacted by demonstrations in the city during the final quarter. Mandarin Oriental, Tokyo benefited from improved visitor arrivals to the city, while occupancy at the Bangkok property continued to be affected by the ongoing political uncertainty in the country. The performances of the Group's other Asian hotels were broadly stable.

The results in Europe benefited from further stabilization of the Paris hotel and an improvement in Geneva, which more than offset weaker demand in London.

In The Americas, while the majority of the Group's hotels reported higher revenue per available room, the overall result was impacted by lower demand in Washington D.C. when compared to the prior year, which included the 2013 Presidential Inauguration.

Outlook

While trading conditions in a number of markets are expected to remain challenging, the Group is in a strong competitive position. Over the longer term, Mandarin Oriental will benefit from the strength of its brand, the increasing number of travellers from emerging markets, particularly mainland China, the limited new supply of luxury hotels in its key mature markets, and the phased opening of new hotels and Residences under development.

Dividends and dividend policy

Subject to the provisions of the Bye-laws and in accordance with the Bermuda Companies Act, the Board intends to continue with its current practice on dividends, taking into account the results of the Company's operations, financial condition, cash requirements, prospects, profits available for distribution and other factors deemed to be relevant at the time. Although the New Ordinary Shares will not be entitled to the final dividend in respect of 2014, the Board considers that, had the share capital as enlarged as a result of the Rights Issue been in place during 2014, the Board would have recommended the same level of dividend per share.

Action to be taken in respect of the Rights Issue

(a) Qualifying Shareholders

Qualifying Shareholders, other than Excluded Shareholders, will be sent a PAL, which will set out the number of New Ordinary Shares which have been provisionally allotted and the procedure for acceptance and payment.

(b) Depositors within CDP

Entitled Depositors who hold Ordinary Shares through CDP are entitled to receive RAFs and such other documents in relation to the Rights Issue as CDP may deem appropriate, which will set out the number of Nil Paid Rights Allocations in respect of the New Ordinary Shares which they may apply for and the procedure for acceptance and payment.

(c) General

Further information on the Rights Issue, including the procedure for acceptance and payment in respect of rights not taken up, will be set out in the Prospectus.

Overseas shareholders

The attention of Qualifying Shareholders who have registered addresses outside Australia, Bermuda, Hong Kong, Singapore and the United Kingdom, or who are citizens or residents of countries other than Australia, Bermuda, Hong Kong, Singapore or the United Kingdom, or who are holding Ordinary Shares for the benefit of such persons (including, without limitation, custodians, nominees, trustees and agents) or who have a contractual or other legal obligation to forward this announcement, the Prospectus, a PAL, a RAF and/or any other document in relation to the Rights Issue to such persons, is drawn to the information which will appear in Part II (Terms and Conditions of the Rights Issue) of the Prospectus. In particular, subject to certain limited exceptions, the Rights Issue is not being made to shareholders in the United States or into any of the other Restricted Territories.

In particular, persons who have registered addresses in or who are resident in, or who are residents or citizens of, countries other than Australia, Bermuda, Hong Kong, Singapore and the United Kingdom should consult their professional advisers as to whether they require any governmental or other consents or need to observe any other formalities to enable them to take up their entitlements to New Ordinary Shares under the Rights Issue.

Further information

Shareholders' attention is drawn to the further information which will be set out in the Prospectus. Shareholders should read the whole of the Prospectus and not rely solely on the information set out in this announcement. In particular, Shareholders should consider the risk factors which will be set out in the Prospectus.

Appendix

Timetable of principal events

Each of the times and dates in the table below is indicative only and may be subject to change. Please read the notes for this timetable set out below.

Notes:

(1) References to local time are to local times in the UK, Singapore or Bermuda, as the case may be.

(2) Nil Paid Rights Allocations cannot be traded on the Singapore Exchange unless the Existing Ordinary Shares pursuant to which the Nil Paid Rights Allocations are granted are held through CDP.

(3) If you hold Ordinary Shares through CDP, please refer to paragraph 2.2 of Part II (Terms and Conditions of the Rights Issue) of the Prospectus.

(4) Or, where payment is made by a US dollar banker's draft not drawn on a bank in Singapore, such later date as the relevant banker's draft is cleared.

Rights Issue Statistics

Notes:

References to closing share prices are to the closing share price quoted on the Singapore Exchange.

(1) On the assumption that no further Ordinary Shares are issued before the Record Date and that the maximum number of New Ordinary Shares is issued, before reduction to take account of fractional entitlements which are being rounded down and disregarded.

(2) Assuming that no further Ordinary Shares are issued as a result of the exercise of any Share Options or Share Awards vesting under any Share Incentive Schemes between 4th March 2015, being the latest practicable date prior to this announcement, and completion of the Rights Issue.

Definitions

- end -